v3.26.3
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating activities:    
Net loss $ (25,869) $ (71,671)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 4,018 4,976
Stock issued for services 50 150
Depreciation 7,626 7,033
Bad debt expense 401 0
Intangibles and other amortization expense 35 35
Debt related fees and amortization expense 2,668 4,831
Accretion and other expenses of Series A preferred units 4,338 6,345
Loss (gain) on sale/disposal of assets 108 (4)
Changes in operating assets and liabilities:    
Accounts receivable (4,363) 517
Inventories (1,937) 20,336
Prepaid expenses (703) 179
Tax credit sale receivable 0 12,300
Section 45Z production tax credits 2,038 0
Other assets 541 (676)
Accounts payable (4,555) (9,238)
Accrued interest expense and fees 32,590 19,484
Other liabilities (7,472) 2,894
Net cash provided by (used in) operating activities 9,514 (2,509)
Investing activities:    
Capital expenditures (35,307) (9,441)
Grant proceeds for capital expenditures 1,440 411
Proceeds from sale of fixed assets 2 0
Net cash used in investing activities (33,865) (9,030)
Financing activities:    
Proceeds from borrowings 37,481 29,246
Repayments of borrowings (23,503) (35,729)
Payments on Series A preferred financing (7,889) (2,200)
Lender debt renewal and waiver fee payments 0 (495)
Payments on finance leases (195) (168)
Proceeds from sales of common stock 15,449 25,487
Proceeds from exercise of stock options 49 257
Net cash provided by financing activities 21,392 16,398
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (50) (138)
Net change in cash, cash equivalents, and restricted cash for period (3,009) 4,721
Cash, cash equivalents, and restricted cash at beginning of period 7,886 3,831
Cash, cash equivalents and restricted cash at end of period 4,877 8,552
Supplemental disclosures of cash flow information, cash paid:    
Cash paid for interest 7,621 12,820
Income taxes paid 0 0
Supplemental disclosures of cash flow information, non-cash transactions:    
Settlement of accounts payable via issuance of common stock 0 45
Fair value of warrants issued to subordinated debt holders 185 584
Subordinated debt extension fees added to debt 340 680
Financing lease liabilities arising from obtaining right of use assets 1,398 0
Lender debt extension, waiver, and other fees added to debt 1,700 2,595
Accrued capital expenditures in construction financing 6,286 0
Capital expenditures in accounts payable and accruals $ 26,252 $ 17,228